Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Although the selective serotonin reuptake inhibitors (SSRIs), which are now widely used as a first-line treatment for depression and many other psychiatric conditions, are generally well tolerated, they are not devoid of side effects. Most short-term treatment-related side effects of SSRIs are transient and disappear after a few days or weeks. However, following long-term treatment with the SSRIs, some serious adverse events may occur. Some of them can be difficult to recognise because they can resemble residual symptoms of depression. The most serious can be life threatening. They all have a negative influence on the patient's quality of life and are frequently a prime reason for a lack of long-term compliance with the associated increased risk of recurrence of a depressive episode. This article is an overview of the more common adverse events, which are seen with non-acute treatment with the SSRIs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional potential challenges include continuation of medication during pregnancy [17] and potential drug interactions [13].”
From Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods (2018) · cites this paper as [13]
In the citing paper
“Although widely used and efficacious [8–10], SRI use long-term is associated with adverse side effects [11–14]”
From Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods (2018) · cites this paper as [13]
In the citing paper
“Psilocybin is typically administered for a few weeks, a considerably shorter duration compared to treatment with SSRIs/SNRIs, which can last several months or years to show and maintain antidepressant effects. 102”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [102]
In the citing paper
“but safety assessment is inherently biased by certain methodological weaknesses of RCTs.These weaknesses include small and unrepresentative samples, rare and inconsistent reporting of adverse outcomes, and short duration of exposures.14,15”
From Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review (2019) · cites this paper as [14]
In the citing paper
“However, SSRIs and SNRIs are associated with a range of side effects, including loss of appetite, weight loss, drowsiness, dizziness, fatigue, headaches, increased suicidal thoughts, nausea/vomiting, sexual dysfunction, and increased risk of cardiovascular and cerebrovascular events [3–5].”
From Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report (2021) · cites this paper as [4]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn
Chambers, C. D., Hernandez-Diaz, S., Van Marter, L. J., Werler, M. M., Louik, C., Jones, K. L., & Mitchell, A. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052744 · Cited by 880
SSRI Antidepressant Medications: Adverse Effects and Tolerability
Ferguson, J. M. (2001) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v03n0105 · Cited by 669 · cited 3×
“On the contrary, sertraline tends to reduce nocturnal wakening (Ferguson, 2001).”
BackgroundInfluentialEffects of SSRIs on Sexual Function: A Critical Review
Rosen, R. C., Lane, R. M., & Menza, M. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 650
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review
Vaswani, M., Linda, F. K., & Ramesh, S. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00338-x · Cited by 612
Association of road-traffic accidents with benzodiazepine use
Barbone, F., McMahon, A., Davey, P., Morris, A., Reid, I., McDevitt, D., & MacDonald, T. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04087-2 · Cited by 559
Emergence of intense suicidal preoccupation during fluoxetine treatment
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.207 · Cited by 532
First-Trimester Use of Selective Serotonin-Reuptake Inhibitors and the Risk of Birth Defects
Louik, C., Lin, A. E., Werler, M. M., Hernández-Díaz, S., & Mitchell, A. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067407 · Cited by 500
Use of Selective Serotonin-Reuptake Inhibitors in Pregnancy and the Risk of Birth Defects
Alwan, S., Reefhuis, J., Rasmussen, S. A., Olney, R. S., & Friedman, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066584 · Cited by 495
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A., & Whyte, I. M. (2004) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 435
Sexual dysfunction before antidepressant therapy in major depression
Kennedy, S. H., Dickens, S. E., Eisfeld, B. S., & Bagby, R. M. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00050-6 · Cited by 412
Dalton, S. O., Johansen, C., Mellemkjær, L., Sørensen, H. T., Nørgård, B., & Olsen, J. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.59 · Cited by 389
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture
Richards, J. B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.2.188 · Cited by 386
Sanz, E. J., De-las-Cuevas, C., Kiuru, A., Bate, A., & Edwards, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17865-9 · Cited by 382
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 331
Diem, S. J. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1240 · Cited by 326
Association of Low Bone Mineral Density With Selective Serotonin Reuptake Inhibitor Use by Older Men
Haney, E. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1246 · Cited by 286
Bérard, A., Ramos, É., Rey, É., Blais, L., St.‐André, M., & Oraichi, D. (2007) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20099 · Cited by 275
Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults
Jacob, S., & Spinier, S. A. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g293 · Cited by 262
Suri, R., Altshuler, L., Hellemann, G., Burt, V. K., Aquino, A., & Mintz, J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06071172 · Cited by 247
Oberlander, T. F., Misri, S., Fitzgerald, C. E., Kostaras, X., Rurak, D., & Riggs, W. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0214 · Cited by 244
Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235
Bar-Oz, B., Einarson, T., Einarson, A., Boskovic, R., O'Brien, L., Malm, H., Bérard, A., & Koren, G. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.003 · Cited by 226
Selective serotonin-reuptake inhibitors: an update
Masand, P. (1999) · Harvard Review of Psychiatry · doi:10.1093/hrp/7.2.69 · Cited by 220
Davis, R. L., Rubanowice, D., McPhillips, H., Raebel, M. A., Andrade, S. E., Smith, D., Yood, M. U., & Platt, R. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1462 · Cited by 203
LOKE, Y. K., TRIVEDI, A. N., & SINGH, S. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03541.x · Cited by 193
Lattimore, K. A., Donn, S. M., Kaciroti, N., Kemper, A. R., Neal, C. R., & Vazquez, D. M. (2005) · Journal of Perinatology · doi:10.1038/sj.jp.7211352 · Cited by 189
Maternal Use of Selective Serotonin Reuptake Inhibitors and Risk of Congenital Malformations
Wogelius, P., Nørgaard, M., Gislum, M., Pedersen, L., Munk, E., Mortensen, P. B., Lipworth, L., & Sørensen, H. T. (2006) · Epidemiology · doi:10.1097/01.ede.0000239581.76793.ae · Cited by 185
Antidepressants and sexual dysfunction
Werneke, U., Northey, S., & Bhugra, D. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00890.x · Cited by 176
Trends in the Development of New Antidepressants. Is there a Light at the End of the Tunnel?
Pacher, P., & Kecskemeti, V. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455594 · Cited by 175
The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly
Juurlink, D. N., Mamdani, M. M., Kopp, A., & Redelmeier, D. A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.5.813 · Cited by 174
Rakel, R. E., & Bope, E. T. (2006) · Therapeutische Umschau · doi:10.1024/0040-5930.63.2.164b · Cited by 173
Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., & Mann, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1044 · Cited by 167
SSRI-Associated Sexual Dysfunction
Balon, R. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1504 · Cited by 166
Paroxetine in the first trimester and the prevalence of congenital malformations
Cole, J. A., Ephross, S. A., Cosmatos, I. S., & Walker, A. M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1463 · Cited by 162
Selective Serotonin Reuptake Inhibitors and Increased Bleeding Risk: Are We Missing Something?
Serebruany, V. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.044 · Cited by 161
Current Trends in the Development of New Antidepressants
Pacher, P., Kohegyi, E., Kecskemeti, V., & Furst, S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013373796 · Cited by 160
Apathy and Indifference in Patients on Fluvoxamine: and Fluoxetine
HOEHN-SARIC, R., LIPSEY, J. R., & McLEOD, D. R. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199010000-00007 · Cited by 156
“Dopamine-Dependent” Side Effects of Selective Serotonin Reuptake Inhibitors: A Clinical Review
Damsa, C., Bumb, A., Bianchi-Demicheli, F., Vidailhet, P., Sterck, R., Andreoli, A., & Beyenburg, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0806 · Cited by 154
Tolerability issues during long-term treatment with antidepressants
Cassano, P., & Fava, M. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490281618 · Cited by 154 · cited 2×
“, 2006) and many older antidepressants (tricyclics and monoamine oxidase inhibitors; Cassano and Fava, 2004).”
BackgroundReexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia.
Rothschild, A. J., & Locke, C. (1991) · PubMed · Cited by 144
Selective Serotonin Reuptake Inhibitors and Risk of Upper GI Bleeding: Confusion or Confounding?
Yuan, Y., Tsoi, K., & Hunt, R. H. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.006 · Cited by 125
(2017) · Journal of Midwifery & Women's Health · doi:10.1111/jmwh.12678 · Cited by 123
Synaptic Effects of Antidepressants
RICHELSON, E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606002-00001 · Cited by 120 · cited 1×
“The therapeutic mechanism of action of SSRIs involves alteration in the 5-hydroxytryptamine, serotonin (5-HT) system (Richelson, 1996).”
BackgroundWilliams, V. S. L., Baldwin, D. S., Hogue, S. L., Fehnel, S. E., Hollis, K. A., & Edin, H. M. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0205 · Cited by 114
Use of Antidepressants Among Elderly Subjects: Trends and Contributing Factors
Mamdani, M. M., Parikh, S. V., Austin, P. C., & Upshur, R. E. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.360 · Cited by 112
Extrapyramidal Symptoms with Selective Serotonin Reuptake Inhibitors
Arya, D. K. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.165.6.728 · Cited by 112
Effect of Mirtazapine Treatment on Body Composition and Metabolism
Laimer, M., Kramer-Reinstadler, K., Rauchenzauner, M., Lechner-Schoner, T., Strauss, R., Engl, J., Deisenhammer, E. A., Hinterhuber, H., Patsch, J. R., & Ebenbichler, C. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0313 · Cited by 103
WESSINGER, S., KAPLAN, M., CHOI, L., WILLIAMS, M., LAU, C., SHARP, L., CROWELL, M. D., KESHAVARZIAN, A., & JONES, M. P. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02859.x · Cited by 96
Problems with currently available antidepressants.
Gumnick, J. F., & Nemeroff, C. B. (2000) · PubMed · Cited by 95
Persistent Sexual Side Effects after SSRI Discontinuation
Csoka, A. B., & Shipko, S. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000091777 · Cited by 92 · cited 1×
“Persistent sexual side effects after SSRI discontinuation have been observed (Csoka and Shipko, 2006).”
BackgroundDriving impairment in depressed patients receiving long-term antidepressant treatment
Wingen, M., Ramaekers, J. G., & Schmitt, J. A. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0471-7 · Cited by 92
Wongpakaran, N., van Reekum, R., Wongpakaran, T., & Clarke, D. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-7 · Cited by 91
Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression
Mourilhe, P. R., & Stokes, P. E. (1998) · Drug Safety · doi:10.2165/00002018-199818010-00005 · Cited by 88
Hedenmalm, K., Güzey, C., Dahl, M.-L., Yue, Q.-Y., & Spigset, O. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000203200.96205.34 · Cited by 85
Do noradrenaline and serotonin differentially affect social motivation and behaviour?
Dubini, A., Bosc, M., & Polin, V. (1997) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00419-7 · Cited by 85
Garland, E. J., & Baerg, E. A. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750284090 · Cited by 80 · cited 2×
“Rare cases of apathy, lack of motivation and frontal lobe syndrome have been reported in adults, adolescents and children treated with SSRIs (Hoehn-Saric, et al., 1990, 1991; George and Trimble, 1992; Garland and Baerg, 2001).”
BackgroundPacher, P., & Ungvari, Z. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1366 · Cited by 80
Metabolic Issues With Atypical Antipsychotics in Primary Care: Dispelling the Myths
Kabinoff, G. S., Toalson, P. A., Healey, K. M., McGuire, H. C., & Hay, D. P. (2003) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v05n0103 · Cited by 77
Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
Turner, M. S., May, D. B., Arthur, R. R., & Xiong, G. L. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01720.x · Cited by 74
Mort, J. R., Aparasu, R. R., & Baer, R. K. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.9.1307 · Cited by 69
(1991) · PubMed · Cited by 66
Managing weight gain as a side effect of antidepressant therapy.
Deshmukh, R., & Franco, K. S. N. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.7.614 · Cited by 57
Himei, A., & Okamura, T. (2006) · CNS Drugs · doi:10.2165/00023210-200620080-00005 · Cited by 56 · cited 2×
“The discontinuation syndrome is most commonly associated with the use of paroxetine and is more likely to occur in patients who experienced adverse reactions in the early phase of treatment (Himei and Okamura, 2006).”
BackgroundTo treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects
AUSTIN, M.-P. (2006) · Psychological Medicine · doi:10.1017/s003329170600835x · Cited by 54
Paroxetine: current status in psychiatry
Pae, C.-U., & Patkar, A. A. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.2.107 · Cited by 53 · cited 1×
“Paroxetine may be more likely than other SSRIs to cause weight gain during both short-term and long-term treatments (Pae and Patkar, 2007).”
BackgroundAntidepressants Reduce the Risk of Suicide among Elderly Depressed Patients
Barak, Y., Olmer, A., & Aizenberg, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300863 · Cited by 47
Diffusion of New Generation Antidepressant Treatment Among Elderly Diagnosed With Depression
Sambamoorthi, U., Olfson, M., Walkup, J. T., & Crystal, S. (2003) · Medical Care · doi:10.1097/00005650-200301000-00019 · Cited by 47
Committee Opinion No. 354: Treatment With Selective Serotonin Reuptake Inhibitors During Pregnancy
(2006) · Obstetrics & Gynecology · doi:10.1097/00006250-200612000-00058 · Cited by 47
Silvestri, R., Pace-Schott, E. F., Gersh, T., Stickgold, R., Salzman, C., & Hobson, J. A. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0812 · Cited by 40
Sexual Impairment in Psychiatric Inpatients: Focus on Depression
Cohen, S., Kühn, K. ‐., Bender, S., Erfurth, A., Gastpar, M., Murafi, A., Rothermundt, M., Signerski-Krieger, J., Sträter, B., Teusch, L., et al. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-970143 · Cited by 39
Ensrud, K. E., Blackwell, T., Ancoli‐Israel, S., Redline, S. S., Yaffe, K. S., Diem, S. J., Claman, D. M., & Stone, K. L. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00880.x · Cited by 38
Lineberry, T. W., Bostwick, J. M., Beebe, T. J., & Decker, P. A. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.4.518 · Cited by 36
Continued Antidepressant Treatment and Suicide in Patients with Depressive Disorder
S⊘ndergård, L., Lopez, A. G., Andersen, P. K., & Kessing, L. V. (2007) · Archives of Suicide Research · doi:10.1080/13811110701249889 · Cited by 35
SSRIs AND THE SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION
ROTTMANN, C. N. (2007) · AJN American Journal of Nursing · doi:10.1097/00000446-200701000-00022 · Cited by 34
Pharmacotherapy of Depression in Pregnancy
Patkar, A. A., Bilal, L., & Masand, P. S. (2004) · Annals of Clinical Psychiatry · doi:10.1080/10401230490453662 · Cited by 32
Syndrome of inappropriate secretion of antidiuretic hormone due to citalopram and venlafaxine
Romero, S., Pintor, L., Serra, M., Plana, T., Navarro, V., Gastó, C., & Goldstein, B. I. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.11.001 · Cited by 26
Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs)
Hedenmalm, K., Sundström, A., & Spigset, O. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1270 · Cited by 26
(1992) · PubMed · Cited by 19
Paroxetine Use During Pregnancy: Is it Safe?
Thormahlen, G. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h116 · Cited by 18
SSRIs & the Risk of Abnormal Bleeding
Reeves, R. R., Wise, P. M., & Cox, S. K. (2007) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20070401-06 · Cited by 13
Severe disturbance occurring during treatment for depression of a bulimic patient with fluoxetine
Hawthorne, M., & Lacey, J. H. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90017-z · Cited by 9
Safety of selective serotonin reuptake inhibitors in pregnancy
Donnelly, A., & Paton, C. (2007) · Psychiatric Bulletin · doi:10.1192/pb.bp.106.012898 · Cited by 4
[Serotonin reuptake inhibitors may increase the risk of osteoporosis].
Lerner, U. H. (2005) · PubMed · Cited by 3
Odar‐Cederlöf, I., Hjelmström, P., Jersenius, I., Andersson, M. L., Rasmanis, G., & Bergman, U. (2006) · PubMed · Cited by 2
Research works printed but not linked: 13
- George, MS, 1992, J Clin Psychiatry, 53, 379
- Guay, D., 2000, Consult Pharm, 15, 160
- Gumnick, JF, 2000, J Clin Psychiatry, 61, 5
- Hoehn-Saric, R., 1991, J Clin Psychiatry, 52, 131
- Kelsey, JE ( 2001) Mood disorders. In: Rakel, RE, Bope, ET (eds), Conn’s Current Therapy. Philadelphia: WB Saunders Company, pp. 1147-1154.
- Lerner, UH, 2005, Lakartidningen, 102, 2746
- Lieberman, JA, 2003, Prim Care Companion J Clin Psychiatry, 5, 6
- 10.3109/hrp.7.2.69 · doi:10.3109/hrp.7.2.69 · Paper page
- Odar-Cederlöf, I., 2006, Lakartidningen, 103, 1112
- Richelson, E., 1996, J Clin Psychiatry, 16, 1S
- Rothschild, AJ, 1991, J Clin Psychiatry, 52, 491
- Ryan, D., 2005, Can Fam Physician, 51, 1087
- 10.1016/s0140-6736(05)70271-3 · doi:10.1016/s0140-6736(05)70271-3 · Paper page
Cited by
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“There are, however, safety issues with SSRIs that require caution (Moret et al., 2009; Roose and Miyazaki, 2005).”
BackgroundCarvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Hudak, R., & Gannon, J. M. (2022) · Current Clinical Practice · doi:10.1007/978-3-030-98709-1_5 · Cited by 306
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Metadata
- Authors
- Moret, C., Isaac, M., & Briley, M.
- Affiliations
- NeuroBiz Consulting & Communication, Castres, France,
- South London and Maudsley NHS Foundation Trust (GB)
- NeuroBiz Consulting & Communication, Castres, France
- Corresponding author
- Moret, C.
- ORCID
- Isaac, M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-07-17
- Volume
- 23
- Issue
- 8
- Pages
- 967-974
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2006895116
- Cited by
- 135
- References
- 87
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 13 · 2023: 14 · 2022: 12 · 2021: 10 · 2020: 11 · 2019: 6 · 2018: 10 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 8 · 2013: 7 · 2012: 10
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- selective serotonin reuptake inhibitors, long-term treatment, adverse drug reactions, antidepressant side effects, depression, medication adherence, depression recurrence, quality of life
- MeSH terms
- Adult, Child, Female, Fetus, Gastrointestinal Hemorrhage, Humans, Hyponatremia, Infant, Newborn, Neonatal Abstinence Syndrome, Pregnancy, Sexual Behavior, Sleep Wake Disorders, Suicide, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.